Aligning patient-centric approaches with personalized medicine and biomarker use is transforming the design of Alzheimer's trials.
John Hubbard, PhD
Advertisement
Articles by John Hubbard, PhD
Advertisement
Latest Updated Articles
Developing New Alzheimer’s Drugs With a Focus on Patient SafetyPublished: October 1st 2015 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
